Cited by 39Multiple Sclerosis Research StudiesNeurogenesis and neuroplasticity mechanismsGut microbiota and health

The microbiota regulates murine inflammatory responses to toxin-induced CNS demyelination but has minimal impact on remyelination

Open access
McMurran, Christopher E., Guzman de la Fuente, Alerie, Penalva, Rosana, Ben Menachem-Zidon, Ofra, Dombrowski, Yvonne, Falconer, John, Gonzalez, Ginez A., Zhao, Chao +8 more·2019·Proceedings of the National Academy of Sciences

Abstract

Significance: People with multiple sclerosis have a microbiota distinct from healthy controls, and there is growing interest in how these differences might contribute to the onset and progression of CNS autoimmunity. However, the impact that the microbiota may also have on the endogenous regeneration of myelin—remyelination—has not yet been explored. Here we show that inflammatory responses during remyelination depend upon the microbiota, being modulated by antibiotics or probiotics or in germ-free mice. In contrast, these interventions had minimal impact on the activity of oligodendrocyte progenitor cells, with only supratherapeutic doses of antibiotics having an inhibitory effect. Our results suggest that endogenous CNS remyelination is largely resilient to interventions that modify the microbiota.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1905787116

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
McMurran, C. E., Guzman de la Fuente, A., Penalva, R., Ben Menachem-Zidon, O., Dombrowski, Y., Falconer, J., Gonzalez, G. A., Zhao, C., Krause, F. N., Young, A. M. H., Griffin, J. L., Jones, C. A., Hollins, C., Heimesaat, M. M., Fitzgerald, D. C., & Franklin, R. J. M.
Affiliations
  • Wellcome/MRC Cambridge Stem Cell Institute (GB)
  • Wellcome–MRC Stem Cell Institute, University of Cambridge, CB2 0AW Cambridge, United Kingdom;
  • Wellcome–Wolfson Institute for Experimental Medicine, Queen’s University Belfast, BT9 7BL Belfast, United Kingdom;
  • Queen's University Belfast (GB)
  • University of Cambridge (GB)
  • Respiratory, Inflammation and Autoimmunity Research, MedImmune Ltd., CB21 6GH Cambridge, United Kingdom;
  • Charité – Universitätsmedizin Berlin (DE)
Corresponding author
  • Fitzgerald, Denise C.
  • Franklin, Robin J. M.
Venue
Proceedings of the National Academy of Sciences
Published
2019-11-18
Volume
116
Issue
50
Pages
25311-25321
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2991319492
Cited by
39
References
65
Citations by year
2026: 1 · 2025: 5 · 2024: 8 · 2023: 3 · 2022: 5 · 2021: 9 · 2020: 7 · 2019: 1
FWCI
4.05
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
  • European Committee for Treatment and Research in Multiple Sclerosis
  • Wellcome Trust (110138/Z/15/Z)
  • Leverhulme Trust
  • Multiple Sclerosis Society
  • Rosetrees Trust
  • Jean Shanks Foundation
  • BIRAX
  • Directorate for Biological Sciences
  • Medical Research Council (MR/P01836X/1, MC_PC_12009, MC_PC_13030, MR/P011705/1)
  • Biotechnology and Biological Sciences Research Council (BB/J01026X/1, BB/N003721/1)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
gut microbiota, central nervous system demyelination, remyelination, multiple sclerosis, antibiotic therapy, probiotics, germ-free mice, oligodendrocyte precursor cells, neuroinflammation, oral microbiota
MeSH terms
Gastrointestinal Microbiome, Remyelination, Animals, Anti-Bacterial Agents, Cell Differentiation, Central Nervous System, Female, Humans, Male, Mice, Inbred C57BL, Multiple Sclerosis, Oligodendroglia, Stem Cells, Probiotics, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review